أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

curium netherlands b.v. - sodium pyrophosphate decahydrate - kit for radiopharmaceutical preparation - 20 milligram(s) - technetium (99mtc) compounds; technetium (99mtc) stannous agent labelled cells

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

essential pharma ltd - carbamazepine - suppositories - 125 milligram - carbamazepine

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

essential pharma ltd - carbamazepine - suppositories - 250 milligram - carbamazepine

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

cardinal health 414, llc - technetium tc-99m tilmanocept (unii: 8ihi69pqtc) (technetium tc-99m tilmanocept - unii:8ihi69pqtc) - tilmanocept 250 ug - lymphoseek is a radioactive diagnostic agent indicated with or without scintigraphic imaging for: none. there are no available data on lymphoseek use in pregnant women. additionally, animal reproduction studies have not been conducted with technetium tc 99m tilmanocept. however, all radiopharmaceuticals, including lymphoseek, have a potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. if considering lymphoseek administration to a pregnant woman, inform the patient about the potential for adverse pregnancy outcomes based on the radiation dose from the drug and the gestational timing of exposure. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risks of major birth defects and miscarriage in clinically recognized pregnancies are 2 to 4% and 15

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

pharmalucence, inc. - technetium tc-99m disofenin (unii: qtj2viw97t) (technetium tc-99m disofenin - unii:qtj2viw97t) - disofenin 20 mg in 10 ml - technetium tc99m disofenin is indicated as a hepatobiliary imaging agent. hepatolite is indicated in the diagnosis of acute cholecystitis as well as to rule out the occurrence of acute cholecystitis in suspected patients with right upper quadrant pain, fever, jaundice, right upper quadrant tenderness and mass or rebound tenderness, but not limited to these signs and symptoms. in otherwise healthy individuals, non-visualization of the gallbladder 4 hours after administration of hepatolite following a 2-6 hour fast and in the presence of activity in the small intestine is indicative of a diagnosis of acute cholecystitis. under the same conditions in an otherwise healthy person, visualization of the gallbladder during a 1 hour scintigraphy is effective in excluding a diagnosis of acute cholecystitis. if the gallbladder is not visualized by 1 hour, scanning must continue for four hours or until the gallbladder is visualized. when the gall bladder fails to appear within the first 60 minutes of imaging after th

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

rotop pharmaka gmbh - mertiatide - kit for radiopharmaceutical preparation - 0.2 milligram(s) - technetium (99mtc) compounds; technetium (99mtc) mertiatide

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

essential-healthcare ltd. - acetylcystein - effervescent tablet - 600 milligram(s) - mucolytics; acetylcysteine

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

ge healthcare as - exametazime - kit for radiopharmaceutical preparation - 500 microgram(s) - technetium (99mtc) compounds; technetium (99mtc) exametazime

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

essential pharma (m) limited - carbamazepine - suppository - 125 milligram(s) - carbamazepine

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

essential pharma (m) limited - carbamazepine - suppository - 250 milligram(s) - carboxamide derivatives; carbamazepine